FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to addictology, and can be used to prevent a progression and/or to suppress an alcoholic impulse by immunising an animal. That is ensured by administering angiotensin I and bovine serum albumin (BSA) conjugate in a dose of 300 mcg/kg.
EFFECT: invention enables reducing the toxic damaging action of ethanol and the intensity of immunological disorders accompanying continuous alcoholisation.
1 dwg, 7 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
MEANS FOR REDUCING ALCOHOL MOTIVATION IN ALCOHOL DEPENDENCE | 2014 |
|
RU2582966C2 |
LOW MOLECULAR WEIGHT MIMETIC OF BRAIN NEUROTROPHIC FACTOR WITH ANALGESIC, ANXIOLYTIC AND ANTIADDICTIVE EFFECTS | 2020 |
|
RU2759023C2 |
CARDIOTROPIC AGENT WITH ANXIOLYTIC AND ANALGESIC PROPERTIES | 2020 |
|
RU2773018C2 |
METHOD FOR ESTIMATING EFFECTIVENESS OF OZONE THERAPY | 2008 |
|
RU2374700C1 |
HYPOLIPIDEMIC AND ANTIISHEMIC AGENT "SERPYSTEN" | 2007 |
|
RU2337701C1 |
AGENT FOR MANAGING ALCOHOL ABSTINENCE SYNDROME | 2012 |
|
RU2521226C2 |
AGENT HAVING ANTI-OXIDANT, ANTI-INFLAMMATORY, NEUROPROTECTIVE, HYPOLIPIDEMIC, HYPOCHOLESTEROLEMIC, HYPOGLYCEMIC, HEPATOPROTECTIVE AND IMMUNOSUPPRESSIVE ACTIVITY | 2012 |
|
RU2487884C1 |
METHOD FOR REDUCTION OF MORBID ATTRACTION TO ETHANOL IN POSTABSTINENT PERIOD | 2007 |
|
RU2373927C2 |
METHOD FOR PREVENTION OF RAT'S LIVER, MYOCARDIUM AND PANCREAS INJURY IN CHRONIC ALCOHOLIC INTOXICATION MODELLING | 2009 |
|
RU2422916C1 |
ANTI-ISHEMIC AND ANTIHYPOXIC AGENT | 2007 |
|
RU2356573C1 |
Authors
Dates
2014-11-20—Published
2011-12-06—Filed